Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Recurrence Risk after Limited Duration of Anticoagulant Treatment for Late Second Venous Thromboembolism

T van der Hulle, M Tan, P L den Exter, M JG van Roosmalen, F JM van der Meer, J Eikenboom, M V Huisman, F A Klok

Blood (2014) 124 (21): 591.

https://doi.org/10.1182/blood.V124.21.591.591

Published: 2014

Journal Articles

Imaging of Von Willebrand Factor Remodeling Upon Secretion From Vascular Endothelial Cells

Marjon J Mourik, Msc, Karine M Valentijn, PhD, Jack A Valentijn, PhD, Jan Voorberg, PhD, Abraham J Koster, PhD, Jeroen C. J. Eikenboom, MD, PhD

Blood (2012) 120 (21): 263.

https://doi.org/10.1182/blood.V120.21.263.263

Published: 2012

Journal Articles

Biogenesis and Exocytosis of Weibel-Palade Bodies Is Affected by Naturally Occurring Von Willebrand Disease Variants within the A1-A3 Domains of VWF

Dafna J Groeneveld, Msc, Jiong-Wei Wang, Msc, Marjon J Mourik, Msc, Richard J Dirven, Bsc, Karine M Valentijn, PhD, Jan Voorberg, PhD, Pieter H. Reitsma, PhD, Jeroen C. J. Eikenboom, MD, PhD

Blood (2012) 120 (21): 1072.

https://doi.org/10.1182/blood.V120.21.1072.1072

Published: 2012

Journal Articles

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Reinhard Schneppenheim, MD, PhD, Ulrich Budde, MD, Javier Batlle, MD, Giancarlo Castaman, MD, Jeroen C. J. Eikenboom, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Tobias Obser, Florian Oyen, Francesco Rodeghiero, MD, Sonja Schneppenheim, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD

Blood (2012) 120 (21): 99.

https://doi.org/10.1182/blood.V120.21.99.99

Published: 2012

Journal Articles

Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies

Eveline A. M. Bouwens, Marjon J. Mourik, Maartje van den Biggelaar, Jeroen C. J. Eikenboom, Jan Voorberg, Karine M. Valentijn, Koen Mertens

Blood (2011) 118 (22): 5947–5956.

https://doi.org/10.1182/blood-2011-05-355354

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease

Daniel J. Hampshire, PhD, Lisa D. Bloomer, MSc, Ahlam M. Al-Buhairan, PhD, Rachael E. Coyle, Raymon N. C. P. Vijzelaar, MSc, David Lillicrap, MD, Paula D. James, MD, Jeroen C. J. Eikenboom, MD, PhD, Reinhard Schneppenheim, MD, PhD, Francesco Rodeghiero, MD, Robert R. Montgomery, MD, Ian R. Peake, PhD, Anne C. Goodeve, PhD

Blood (2010) 116 (21): 2218.

https://doi.org/10.1182/blood.V116.21.2218.2218

Published: 2010

Journal Articles

Variations in glycosylation of von Willebrand factor with O -linked sialylated T antigen are associated with its plasma levels

Carina J. M. van Schooten, Cécile V. Denis, Ton Lisman, Jeroen C. J. Eikenboom, Frank W. Leebeek, Jenny Goudemand, Edith Fressinaud, H. Marijke van den Berg, Philip G. de Groot, Peter J. Lenting

Blood (2006) 109 (6): 2430–2437.

https://doi.org/10.1182/blood-2006-06-032706

Published: 2006

Journal Articles

ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854Gln, and the missense mutation Cys2362Phe

Giancarlo Castaman, Jeroen C. J. Eikenboom

Blood (2002) 100 (5): 1927–1928.

https://doi.org/10.1182/blood-2002-04-1168

Published: 2002

Journal Articles

Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins

Imre Bodó, Akira Katsumi, Elodee A. Tuley, Jeroen C. J. Eikenboom, Zhengyu Dong, J. Evan Sadler

Blood (2001) 98 (10): 2973–2979.

https://doi.org/10.1182/blood.V98.10.2973

Published: 2001

Journal Articles

Desmopressin-induced thrombocytopenia in von Willebrand disease patients with the Arg611His mutation in the A1 domain of von Willebrand factor [letter; comment]

G Castaman, F Rodeghiero, J Eikenboom

Blood (1996) 87 (7): 3061.

https://doi.org/10.1182/blood.V87.7.3061a.bloodjournal8773061a

Published: 1996

NARROW

Recurrence Risk after Limited Duration of Anticoagulant Treatment for Late Second Venous Thromboembolism

Imaging of Von Willebrand Factor Remodeling Upon Secretion From Vascular Endothelial Cells

Biogenesis and Exocytosis of Weibel-Palade Bodies Is Affected by Naturally Occurring Von Willebrand Disease Variants within the A1-A3 Domains of VWF

Intracellular Retention, Enhanced Clearance, and Defective FVIII Binding Are Common Features of Von Willebrand Factor D'-D3 Domain Mutations in Patients with Von Willebrand Disease Type 1 From the European Mcmdm-1VWD Study

Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies

Investigation of the Role of Copy Number Variation In the Pathogenesis of Type 1 Von Willebrand Disease

Variations in glycosylation of von Willebrand factor with O -linked sialylated T antigen are associated with its plasma levels

ABO blood group also influences the von Willebrand factor (VWF) antigen level in heterozygous carriers of VWF null alleles, type 2N mutation Arg854Gln, and the missense mutation Cys2362Phe

Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins

Desmopressin-induced thrombocytopenia in von Willebrand disease patients with the Arg611His mutation in the A1 domain of von Willebrand factor [letter; comment]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only